• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2022 Fiscal Year Final Research Report

The role of anterior cingulate cortical microglia in pathophysiology of neuropathic pain and novel drug targets

Research Project

  • PDF
Project/Area Number 20K07291
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 48030:Pharmacology-related
Research InstitutionHiroshima University

Principal Investigator

Hisaoka-Nakashima Kazue (久岡一恵)  広島大学, 医系科学研究科(薬), 助教 (20393431)

Co-Investigator(Kenkyū-buntansha) 森岡 徳光  広島大学, 医系科学研究科(薬), 教授 (20346505)
中村 庸輝  広島大学, 医系科学研究科(薬), 助教 (60711786)
Project Period (FY) 2020-04-01 – 2023-03-31
Keywordsミクログリア / 神経障害性疼痛
Outline of Final Research Achievements

In this study, we are intended to elucidate the role of microglia in pathophysiology of neuropathic pain by using partial sciatic nerve ligation (PSNL) model mice. Inhibition of microglia activation by minocycline, local hippocampal microglia depletion with clodronate liposome, or inhibition of high mobility group box-1 (HMGB1) by GZA and anti-HMGB1 antibody blocked cognitive impairment induced by PSNL. Cognitive impairment could be due to degenerative changes in contralateral hippocampal neurons, as observed in PSNL mice. Treatment with anti-HMGB1 antibody blocked PSNL-induced degenerative effects observed in hippocampal neurons. Thus, HMGB1-mediated microglial activation and changes neuronal plasticity could be related to cognitive impairment associated with neuropathic pain.

Free Research Field

薬理学

Academic Significance and Societal Importance of the Research Achievements

慢性疼痛が如何にして脳ミクログリアを活性化するのかは、これまで全く不明であったが、本研究はミクログリア活性化に対するHMGB1の関与を明らかにした。これらの独自の知見を切り口として、慢性疼痛時に活性化する脳ミクログリアの機能と役割について見出すことが出来れば、鎮痛薬の創薬ターゲットとしてのミクログリアの新たな可能性を創造することができる。

URL: 

Published: 2024-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi